Human Telomerase Reverse Transcriptase (hTERT): A Target Molecule for the Treatment of Cisplatin-resistant Tumors-Reference-Cited by-同舟云学术

Human Telomerase Reverse Transcriptase (hTERT): A Target Molecule for the Treatment of Cisplatin-resistant Tumors

Author:

Park Yuk Pheel¹,Kim Kwang Dong²,Kang Seong Ho³,Yoon Do-Young⁴,Park Joo Won⁵,Kim Jong Wan⁵,Lee Hee Gu¹

Affiliation:

1. Medical Genomic Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea

2. Division of Applied Life Science, Gyeongsang National University, Jinju, Korea

3. Department of Chemistry and Basic Science Research Institute, Chonbuk National University, Jeonju, Korea

4. Department of Bioscience and Biotechnology, Konkuk University, Seoul, Korea

5. Department of Laboratory Medicine, College of Medicine Dankook University, Cheonan, Korea

Funder

Ministry of Education, Science and Technology

Publisher

Annals of Laboratory Medicine

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

Reference35 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Telomerase and drug resistance in cancer;Cellular and Molecular Life Sciences;2017-06-16